NCT05874804Completed
Carry Life@ UF System Clinical Study
A Clinical Study With the Carry Life® UF System in Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients
Source: ClinicalTrials.gov · Last updated 22 Dec 2025
Brief summary (registry, in English)
The Carry Life UF system performs peritoneal ultrafiltration by adding glucose to the low glucose strength (1.36%) peritoneal dialysis fluid which has been instilled into the peritoneal cavity prior to the connection of the device. By maintaining a stable glucose concentration in the intraperitoneal fluid during the 5-hour treatment, the ultrafiltration can be increased compared to a standard CAPD dwell.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 28 (actual)
- First submitted
- 18 Apr 2023
- Start date
- 19 Sept 2023
- Primary completion date
- 24 Oct 2025
- Lead sponsor
- Triomed AB
- Diseases
- Chronic kidney disease
- NCT number
- NCT05874804
What you commit to
- Study type: Interventional
- Participants enrolled: 28
- From 19 Sept 2023 to the primary completion date, 24 Oct 2025
- 11 sites in 3 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participation in clinical trials, interfering with the present study, within the previous month.
- Anticipated living donor kidney transplantation within six (6) months of screening.
Other illness
- Clinical condition of unstable diabetes.
- Evidence of any other diseases or medical conditions that may interfere with the planned treatment or affect participant compliance.
Lab values
- A PD prescription including a regular 3.86% glucose day dwell.
- Serum potassium \> 6 mmol/l within the last three (3) months.
- Serum urea \> 35 mmol/l within the last three (3) months.
Other
- An episode of peritonitis within the last three (3) months.
- Clinical signs of dehydration.
- Systolic blood pressure \< 100 mmHg within the last month.
- Known diagnosis of clinically significant aortic stenosis.
- Subjects with a life expectancy of \< six (6) months.
- Pregnant, breastfeeding, or women of childbearing potential who are not using an effective method of contraception (hormonal contraceptives or barrier contraceptive methods).
Who the study is looking for
- Age ≥ 18 years.
- Subjects with ESKD treated with PD for at least three (3) months.
- A PD prescription of 2-4 CAPD dwells/day unchanged for a minimum of two (2) weeks, with at least one 1.5-2L, 2.27% glucose day dwell daily.
- Subjects must be able to tolerate a 2 L PD fill volume for the PET.
- Subjects using the Baxter PD system with a MiniCap transfer set.
- In the opinion of the Investigator, the subject has the capacity to learn how to use the Carry Life® UF system or has a caregiver who can do so.
- Obtained written consent to participate in the study.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (11)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Heartlands Hospital Coordinator of this site? Confirm its status | Birmingham | United Kingdom | Unknown status |
| Queen Elisabeth's Hospital Coordinator of this site? Confirm its status | Birmingham | United Kingdom | Unknown status |
| London Royal Hospital, Barth Health NHS Trust Coordinator of this site? Confirm its status | London | United Kingdom | Unknown status |
| Royal Free London NHS Foundation Trust Coordinator of this site? Confirm its status | London | United Kingdom | Unknown status |
| King's College Hospital Coordinator of this site? Confirm its status | London | United Kingdom | Unknown status |
| Nottingham University Hospitals NHS Trust Coordinator of this site? Confirm its status | Nottingham | United Kingdom | Unknown status |
| ASST Cremona Coordinator of this site? Confirm its status | Cremona | Italy | Unknown status |
| Polyclinic Milan Coordinator of this site? Confirm its status | Milan | Italy | Unknown status |
| Sahlgrenska Universitetssjukhuset Coordinator of this site? Confirm its status | Gothenburg | Sweden | Unknown status |
| Skånes University Hospital Coordinator of this site? Confirm its status | Lund | Sweden | Unknown status |
| Karolinska Universitetssjukhuset, Njurmedicin Rosenlund Coordinator of this site? Confirm its status | Stockholm | Sweden | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.